1887

Microbiology Society logo

Volume 153, Issue 11

Protein FOG is a moderate inducer of MIG/CXCL9, and group G streptococci are more tolerant than group A streptococci to this chemokine's antibacterial effect Free

Abstract

subsp. (group G streptococci; GGS) cause disease in humans but are often regarded as commensals in comparison with (group A streptococci; GAS). The current study investigated the degree and kinetics of the innate immune response elicited by the two species. This was assessed as expression of the chemokine MIG/CXCL9 and bacterial susceptibility to its bactericidal effect. No significant difference in MIG/CXCL9 expression from THP-1 or Detroit 562 cells was observed when comparing whole GGS or GAS as stimuli. The study demonstrates that protein FOG was released from the bacterial surface directly and by neutrophil elastase. Expression of MIG/CXCL9 following stimulation with soluble M proteins of the two species (the recently described protein FOG of GGS and protein M1 of GAS) was reduced for protein FOG in both the monocytic and the epithelial cell line. When the antibacterial effects of MIG/CXCL9 were examined in conditions of increased ionic strength, MIG/CXCL9 killed GAS more efficiently than GGS. Also in the absence of MIG/CXCL9, GGS were more tolerant to increased salt concentrations than GAS. In summary, both GGS and GAS evoke MIG/CXCL9 expression but they differ in susceptibility to its antibacterial effects. This may in part explain the success of GGS as a commensal and its potential as a pathogen.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
Keyword(s): AMPs, antimicrobial peptides , BSA, bovine serum albumin , FOG, fibrinogen-binding protein of GGS , GAS, group A streptococci , GGS, group G streptococci , HSA, human serum albumin , IFN, interferon and MIG, monokine induced by interferon γ
SGM
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.2007/009647-0
2007-11-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/153/11/3800.html?itemId=/content/journal/micro/10.1099/mic.0.2007/009647-0&mimeType=html&fmt=ahah

References

  1. Åkesson P., Schmidt K. H., Cooney J., Björck L. 1994; M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J 300:877–886
     [Google Scholar]
  2. Auckenthaler R., Hermans P. E., Washington J. A. II 1983; Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis 5:196–204
     [Google Scholar]
  3. Bals R., Wang X., Wu Z., Freeman T., Bafna V., Zasloff M., Wilson J. M. 1998; Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102:874–880
     [Google Scholar]
  4. Berge A., Björck L. 1995; Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270:9862–9867
     [Google Scholar]
  5. Björck L., Kronvall G. 1984; Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 133:969–974
     [Google Scholar]
  6. Björck L., Kastern W., Lindahl G., Widebäck K. 1987; Streptococcal protein G, expressed by streptococci or by Escherichia coli, has separate binding sites for human albumin and IgG. Mol Immunol 24:1113–1122
     [Google Scholar]
  7. Bowler P. G., Duerden B. I., Armstrong D. G. 2001; Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14:244–269
     [Google Scholar]
  8. Cole A. M., Ganz T., Liese A. M., Burdick M. D., Liu L., Strieter R. M. 2001; Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 167:623–627
     [Google Scholar]
  9. Cunningham M. W. 2000; Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470–511
     [Google Scholar]
  10. Dieleman L. A., Hoentjen F., Qian B. F., Sprengers D., Tjwa E., Torres M. F., Torrice C. D., Sartor R. B., Tonkonogy S. L. 2004; Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol 136:30–39
     [Google Scholar]
  11. Egesten A., Eliasson M., Johansson H. M., Olin A. I., Mörgelin M., Müeller A., Pease J. E., Frick I. M., Björck L. 2007; The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 195:684–693
     [Google Scholar]
  12. Eliasson M., Frick I. M., Collin M., Sorensen O. E., Bjorck L., Egesten A. 2007; M1 protein of Streptococcus pyogenes increases production of the antibacterial CXC chemokine MIG/CXCL9 in pharyngeal epithelial cells. Microb Pathog Aug 1: [Epub ahead of print]
    [Google Scholar]
  13. Fischetti V. A. 1989; Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2:285–314
     [Google Scholar]
  14. Goebeler M., Toksoy A., Spandau U., Engelhardt E., Brocker E. B., Gillitzer R. 1998; The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions. J Pathol 184:89–95
     [Google Scholar]
  15. Goldman M. J., Anderson G. M., Stolzenberg E. D., Kari U. P., Zasloff M., Wilson J. M. 1997; Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553–560
     [Google Scholar]
  16. Granucci F., Ricciardi-Castagnoli P. 2003; Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces. Curr Opin Microbiol 6:72–76
     [Google Scholar]
  17. Hashikawa S., Iinuma Y., Furushita M., Ohkura T., Nada T., Torii K., Hasegawa T., Ohta M. 2004; Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 42:186–192
     [Google Scholar]
  18. Herwald H., Cramer H., Mörgelin M., Russell W., Sollenberg U., Norrby-Teglund A., Flodgaard H., Lindbom L., Björck L. 2004; M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116:367–379
     [Google Scholar]
  19. Heumann D., Barras C., Severin A., Glauser M. P., Tomasz A. 1994; Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62:2715–2721
     [Google Scholar]
  20. Honore P. M., Lozana A., Defalque D., Estratiou A. 1996; Fatal septic shock due to Lancefield group G streptococci. Acta Clin Belg 51:57–60
     [Google Scholar]
  21. Johansson H. M., Mörgelin M., Frick I. M. 2004; Protein FOG – a streptococcal inhibitor of neutrophil function. Microbiology 150:4211–4221
     [Google Scholar]
  22. Lewthwaite P., Parsons H. K., Bates C. J., McKendrick M. W., Dockrell D. H. 2002; Group G streptococcal bacteraemia: an opportunistic infection associated with immune senescence. Scand J Infect Dis 34:83–87
     [Google Scholar]
  23. Liao F., Rabin R. L., Yannelli J. R., Koniaris L. G., Vanguri P., Farber J. M. 1995; Human MIG chemokine: biochemical and functional characterization. J Exp Med 182:1301–1314
     [Google Scholar]
  24. Miörner H., Johansson G., Kronvall G. 1983; Lipoteichoic acid is the major cell wall component responsible for surface hydrophobicity of group A streptococci. Infect Immun 39:336–343
     [Google Scholar]
  25. Müller-Alouf H., Alouf J. E., Gerlach D., Ozegowski J. H., Fitting C., Cavaillon J. M. 1994; Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun 62:4915–4921
     [Google Scholar]
  26. Navarre W. W., Schneewind O. 1999; Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63:174–229
     [Google Scholar]
  27. Nitsche D. P., Johansson H. M., Frick I. M., Mörgelin M. 2006; Streptococcal protein FOG, a novel matrix adhesin interacting with collagen I in vivo. J Biol Chem 281:1670–1679
     [Google Scholar]
  28. Nitsche-Schmitz D. P., Johansson H., Sastalla I., Reissmann S., Frick I. M., Chhatwal G. S. 2007; Group G streptococcal IgG binding molecules FOG and protein G have different impact on opsonization by C1q. J Biol Chem 282:17530–17536
     [Google Scholar]
  29. Norrby-Teglund A., Chatellier S., Low D. E., McGeer A., Green K., Kotb M. 2000; Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 30:3247–3255
     [Google Scholar]
  30. Oster H. R., Bisno A. L. 2000 Group C and G Streptococcal Infections: Epidemiologic and Clinical Aspects Washington, DC: American Society for Microbiology;
  31. Rodrigues M. E., Melo M. C., Reis F. J., Penna F. J. 1994; Concentration of electrolytes in the sweat of malnourished children. Arch Dis Child 71:141–143
     [Google Scholar]
  32. Schmid J., Hunter P. R., White G. C., Nand A. K., Cannon R. D. 1995; Physiological traits associated with success of Candida albicans strains as commensal colonizers and pathogens. J Clin Microbiol 33:2920–2926
     [Google Scholar]
  33. Simpson W. J., Robbins J. C., Cleary P. P. 1987; Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog 3:339–350
     [Google Scholar]
  34. Sylvetsky N., Raveh D., Schlesinger Y., Rudensky B., Yinnon A. M. 2002; Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med 112:622–626
     [Google Scholar]
  35. van der Merwe D. E., Ubbink J. B., Delport R., Becker P., Dhatt G. S., Vermaak W. J. 2002; Biological variation in sweat sodium chloride conductivity. Ann Clin Biochem 39:39–43
     [Google Scholar]
  36. Vartian C., Lerner P. I., Shlaes D. M., Gopalakrishna K. V. 1985; Infections due to Lancefield group G streptococci. Medicine (Baltimore) 64:75–88
     [Google Scholar]
  37. Veckman V., Miettinen M., Matikainen S., Lande R., Giacomini E., Coccia E. M., Julkunen I. 2003; Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J Leukoc Biol 74:395–402
     [Google Scholar]
  38. Whicher J. T., Evans S. W. 1990; Cytokines in disease. Clin Chem 36:1269–1281
     [Google Scholar]
  39. Yang D., Chen Q., Hoover D. M., Staley P., Tucker K. D., Lubkowski J., Oppenheim J. J. 2003; Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74:448–455
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.2007/009647-0
Loading
Protein FOG is a moderate inducer of MIG/CXCL9, and group G streptococci are more tolerant than group A streptococci to this chemokine's antibacterial effect
Microbiology 153, 3800 (2007); https://doi.org/10.1099/mic.0.2007/009647-0
/content/journal/micro/10.1099/mic.0.2007/009647-0
/content/journal/micro/10.1099/mic.0.2007/009647-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error